Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 9.18M | 14.82% | $ 61.95M |
3/31/2025 | $ 5.83M | 9.76% | $ 59.76M |
12/31/2024 | $ 5.22M | 9.77% | $ 53.4M |
9/30/2024 | $ -9.04M | -19.8% | $ 45.67M |
6/30/2024 | $ -14.45M | -37.96% | $ 38.05M |
3/31/2024 | $ 8.41M | 14.1% | $ 59.65M |
12/31/2023 | $ 10.46M | 15.97% | $ 65.49M |
9/30/2023 | $ 14.74M | 23.17% | $ 63.63M |
6/30/2023 | $ 12.87M | 19.08% | $ 67.46M |
3/31/2023 | $ -12.79M | -31.09% | $ 41.14M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ 2.07M ] / Revenues [ $ 61.16M ]
(=) EBIT % [ 3.39% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |